Carve-outs
A carve-out is two transactions wearing one signature page
You are buying a business, and you are also building an entity that has never existed. The second transaction has no purchase ag…
7 August 2026 · 5 min
Kimberly-Clark did not buy a division of Johnson & Johnson. It bought a company that spent two years being built out of one, and that is the difference between a carve-out that sells and a carve-out that sits. The sequence matters more than the price.
All M&A Research
Carve-outs and separations
Updated
Key takeaways
Most of the coverage of Kimberly-Clark’s purchase of Kenvue treated it as a consumer goods story: Kleenex and Huggies meeting Tylenol and Neutrogena, with about $2.1bn of promised run-rate synergies to justify the cheque. That is the business story. The transaction story is more useful to anyone who will one day sell part of their own company, and it has almost nothing to do with the price.
Kimberly-Clark did not buy a division of Johnson & Johnson. By the time it signed, there was no division to buy. It bought a listed company with its own balance sheet, its own management, its own auditors and its own supply contracts, and every one of those things had been constructed, at J&J’s expense and on J&J’s timetable, in the two years before Kimberly-Clark arrived.
The timeline is worth setting out plainly, because the length of it is the point.
| Date | What happened |
|---|---|
| November 2021 | J&J announces its intention to separate the consumer health business |
| April 2023 | J&J transfers substantially all of the assets and liabilities of the consumer health business to Kenvue |
| May 2023 | Kenvue lists on the NYSE at $22.00 a share |
| August 2023 | J&J completes an exchange offer covering 80.1% of Kenvue’s stock, completing the separation |
| November 2025 | Kimberly-Clark agrees to acquire Kenvue |
| November 2026 | The acquisition completes |
Roughly two years from announcement to a separated company, and another three before a buyer took the whole thing. Nobody paid J&J a fee for the first two years. There was no purchase agreement for that work and no closing date. It was, as the phrase goes, two transactions wearing one signature page: except here they were years apart, and the second one was only possible because the first had been finished.
A buyer can pay for a business. It cannot pay for a business that does not yet exist as a business.
Look at what Kimberly-Clark agreed to pay. The headline enterprise value of about $48.7bn was struck against Kimberly-Clark’s own share price on 31 October 2025, which put the consideration at roughly $21.01 for each Kenvue share: $3.50 in cash plus 0.14625 of a Kimberly-Clark share. On completion the company issued around 281.1 million of its own shares and paid approximately $6.7bn in cash.
That is a conventional cash-and-stock structure, and it was only available because the target was a conventional company. You can agree a fixed exchange ratio against a listed entity with audited accounts. You cannot agree one against a set of allocated management accounts and a promise to extract the business later.
The regulators treated it as a company too. The European Commission cleared the deal subject to remedies, with Kimberly-Clark agreeing to divest certain feminine hygiene brands in the European Economic Area. The kind of condition you can only impose, and only satisfy, when the assets are already ring-fenced and saleable on their own.
None of this is a mega-deal phenomenon. It is the ordinary mechanics of selling a division, and it shows up in every size of transaction.
When an owner decides to sell one site, one product line or one subsidiary, the business being sold usually has:
A buyer facing that will do one of three things: discount the price for the work and risk, slow the deal down while it quantifies them, or walk. All three cost the seller money. J&J spent two years and considerable expense avoiding all three.
The uncomfortable conclusion is that the cheapest moment to do separation work is before you are in a process, when you are not negotiating against a deadline and nobody is reading your answers as a concession.
In practice that means knowing, before you go to market: what the business actually costs to run when nobody else is paying for anything; which contracts have to be re-papered and at what price; who has to transfer and who has to be hired; and what a normal level of working capital looks like for it as a standalone operation.
That is unglamorous work, and it is the work that decides whether you are selling a company or selling a project. Kimberly-Clark paid $48.7bn for a company. Nobody would have paid that for a project.
The figures and dates above come from the parties’ own filings and announcements. Deal values and status for current transactions are tracked by M&A News, which lists every merger and acquisition above $250m announced this year.
Related
Carve-outs
You are buying a business, and you are also building an entity that has never existed. The second transaction has no purchase ag…
7 August 2026 · 5 min
Deal structure
Buyers want assets and sellers want shares, for the same reason: one of them leaves the history behind. Where that argument land…
9 November 2026 · 4 min
Tools
No single room wins every deal, so this is organised by the process you are running rather than as a ranking. With what each pro…
9 November 2026 · 11 min